Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Observational × Venous Thromboembolism × Dabigatran × Clear all

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 2 Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thromboembolism 2 Neoplasms 1 Myeloproliferative Disorders 1 Embolism 1

Interventions

Rivaroxaban 4 apixaban 3 Dabigatran 2 ribociclib 1 palbociclib 1 edoxaban 1 calcium heparin 1 abemaciclib 1 Tinzaparin 1 Surveys and Questionnaires 1 Observation 1 Mass Screening 1 Heparin, Low-Molecular-Weight 1 Heparin 1 Fondaparinux 1 Enoxaparin 1 Data Collection 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04618913 2026-03-12

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT03965741 2021-11-30

PRACTISE

Bayer

97,765 enrolled

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡